EANS-News: Marseille-Kliniken AG confirms earnings improvement in Q1 2011/2012

--------------------------------------------------------------------------------
Corporate news transmitted by euro adhoc. The issuer/originator is solely
responsible for the content of this announcement.
--------------------------------------------------------------------------------

3-month report

Subtitle: - Group net profit up sharply from € 0.3 million to € 1.5
million - Revenues stable at € 48.2 million - Significant increase in
EBIT expected for the current financial year

Hamburg, Germany (euro adhoc) - 16 November 2011 - Marseille-Kliniken
AG confirms the statement made on 7 November 2011 on its performance
in the first quarter of the financial year 2011/2012. In the first
three months of the current financial year (1 July to 30 September
2011) Group net profit rose fivefold from EUR 0.3 million to EUR 1.5
million. The occupancy rate improved by 1.4 percentage points to
88.5%, beating last year´s average of 87.1%. Revenues were stable at
EUR 48.2 million (previous year: EUR 49.1 million). "The performance
in the first quarter of 2011/2012 shows that our strategic
realignment not only had a positive impact on earnings for the
2010/2011 financial year, but that it is still visible in the current
figures. We expect these positive developments to continue for the
full financial year," said Michael Thanheiser, Chairman of
Marseille-Kliniken AG.

In the last financial year 2010/2011 Marseille-Kliniken AG pursed its
strategic reorientation by focusing on its core competences in
inpatient and outpatient nursing care for the elderly, strengthening
its quality leadership and introducing a new decentralised management
structure (the regional manager structure). Building on these
foundations, total expenses were cut from EUR 49.4 million to EUR
46.4 million in the first quarter of 2011/2012. One specific example
was the previously loss-making facility AMARITA Hamburg-Mitte, which
reached break-even in the first quarter of 2011/2012.Revenues came to
EUR 46.9 million in the first quarter of last year, not including the
loss-making Montabaur site, which was sold in October 2010. On a
like-for-like basis for the continuing operations, overall revenues
went up by around EUR 1.3 million, which further underlines the
improvement in Marseille-Kliniken AG´s results. Marseille-Kliniken AG
operates 60 nursing facilities throughout Germany, with a headline
capacity of 7,960 beds.

In view of the first quarter´s earnings, Marseille-Kliniken AG
affirms its forecast for the current financial year 2011/2012 of
Group EBIT well above last year´s and a slight increase in revenues.
Furthermore, the strategic focus will be on optimising the core
nursing business and improving the financing arrangements.

The full quarterly report is available to the public on the company´s
website www.marseille-kliniken.de as of today.

Further inquiry note:
Christian Hillermann
Hillermann Consulting
Investor Relations for Marseille-Kliniken AG
Poststraße 14/16
20354 Hamburg
Germany
Tel.: +49-(0)40 / 320 279-10
Fax: +49-(0)40 / 320 279-114
www.marseille-kliniken.com

end of announcement euro adhoc
--------------------------------------------------------------------------------

company: Marseille-Kliniken AG
Alte Jakobstraße 79/80
D-10179 Berlin
phone: +49 (0)30 246 32-400
FAX: +49 (0)30 246 32-401
mail: info@marseille-kliniken.de
WWW: http://www.marseille-kliniken.de
sector: Pharmaceuticals
ISIN: DE0007783003
indexes: CDAX, Classic All Share, Prime All Share
stockmarkets: regulated dealing/prime standard: Frankfurt, free trade: Berlin,
Stuttgart, Düsseldorf, regulated dealing: Hamburg
language: English